---
figid: PMC9208469__DDDT-16-1827-g0001
figtitle: 'Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic
  Porphyria: Design, Development, and Place in Therapy'
organisms:
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Caenorhabditis elegans
- Human immunodeficiency virus 1
- Hepatitis B virus
- Homo sapiens
- Oryctolagus cuniculus
- Nicotiana tabacum
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC9208469
filename: DDDT-16-1827-g0001.jpg
figlink: /pmc/articles/PMC9208469/figure/f0001/
number: F1
caption: The pathway of heme synthesis, showing pathway intermediates and end-product
  regulation by heme. The eight steps of heme synthesis (left column) are shown with
  the enzyme (middle column) that catalyzes each step. The enzymes in bold type are
  the clinically most prevalent porphyrias. From The New England Journal of Medicine,
  Bissell DM, Anderson KE, Bonkovsky HL, Porphyria, 377(9), 862–872. Copyright © (2017)
  Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical
  Society.
papertitle: 'Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic
  Porphyria: Design, Development, and Place in Therapy.'
reftext: Chaudry Nasir Majeed, et al. Drug Des Devel Ther. 2022;16:1827-1845.
year: '2022'
doi: 10.2147/DDDT.S281631
journal_title: Drug Design, Development and Therapy
journal_nlm_ta: Drug Des Devel Ther
publisher_name: Dove
keywords: givosiran | small interfering RNA’s | siRNAs | 5- (or δ)-aminolevulinic
  acid synthase 1 (ALAS1) expression inhibitors | porphyrias
automl_pathway: 0.7693856
figid_alias: PMC9208469__F1
figtype: Figure
redirect_from: /figures/PMC9208469__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9208469__DDDT-16-1827-g0001.html
  '@type': Dataset
  description: The pathway of heme synthesis, showing pathway intermediates and end-product
    regulation by heme. The eight steps of heme synthesis (left column) are shown
    with the enzyme (middle column) that catalyzes each step. The enzymes in bold
    type are the clinically most prevalent porphyrias. From The New England Journal
    of Medicine, Bissell DM, Anderson KE, Bonkovsky HL, Porphyria, 377(9), 862–872.
    Copyright © (2017) Massachusetts Medical Society. Reprinted with permission from
    Massachusetts Medical Society.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Coa
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Dl
  - .na.character
  - Tapdelta
  - deltaTry
  - ix
  - FeCH
  - Cyp4g1
  - Cyp4d1
  - Cyp4d2
  - Cyp4ae1
  - Cyp18a1
  - Cyp4e3
  - Cyp6a2
  - Cyp9b1
  - Cyp9b2
  - Cyp4e2
  - Cyp6a9
  - Cyp6a21
  - Cyp6a8
  - Cyp9c1
  - Cyp4d8
  - Cyp4c3
  - Cyp4e1
  - Cyp4p1
  - Cyp6a22
---
